Cargando…

Tumor lysis Syndrome in a Patient with Metastatic Breast Cancer Treated with Alpelisib

PURPOSE: Tumor lysis syndrome (TLS) is a rare but life-threatening phenomenon that occurs mainly in patients with aggressive hematologic or highly chemotherapy sensitive solid tumors such as high-grade neuroendocrine carcinoma or testicular cancer. Tumor lysis syndrome is exceedingly rare in hormone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handy, Caitlin, Wesolowski, Robert, Gillespie, Michelle, Lause, Michael, Sardesai, Sagar, Williams, Nicole, Grimm, Michael, Kassem, Mahmoud, Ramaswamy, Bhuvaneswari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408891/ https://www.ncbi.nlm.nih.gov/pubmed/34483661 http://dx.doi.org/10.1177/11782234211037421

Ejemplares similares

Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
por: Sardesai, Sagar, et al.
Publicado: (2020)

LPTO-10. ASSESSMENT OF LEPTOMENINGEAL CARCINOMATOSIS DIAGNOSIS AND OUTCOMES FROM 2005 TO 2015 AT THE OHIO STATE UNIVERSITY
por: Williams, Nicole, et al.
Publicado: (2019)

The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Johnson, Kai Conrad Cecil, et al.
Publicado: (2023)

Alpelisib for breast cancer
Publicado: (2022)

Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies
por: Grimm, Michael, et al.
Publicado: (2022)

TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature
por: Boutrid, Hinda, et al.
Publicado: (2020)

Metastatic breast cancer patient perceptions of somatic tumor genomic testing
por: Adams, Elizabeth J., et al.
Publicado: (2020)

Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
por: Mal, Rahul, et al.
Publicado: (2020)

Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer
por: Al Zeyoudi, Jawaher, et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer
por: Abufaied, Mohamad, et al.
Publicado: (2021)

A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature
por: Patel, Sandipkumar H, et al.
Publicado: (2021)

Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series
por: Blow, Tahj, et al.
Publicado: (2021)

Diabetic Ketoacidosis With Alpelisib
por: Jeun, Rebecca, et al.
Publicado: (2021)

Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls
por: Johnson, Kai CC, et al.
Publicado: (2023)

A multidisciplinary approach to optimizing care of patients treated with alpelisib
por: Rugo, Hope S., et al.
Publicado: (2021)

Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer
por: Ge, Xuan, et al.
Publicado: (2023)

Alpelisib-Induced Diabetic Ketoacidosis
por: Espinosa, Luis Borges, et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis
por: Nguyen, Paul, et al.
Publicado: (2021)

MON-678 Worsening Diabetes Control in Breast Cancer Patients Treated with Alpelisib
por: Geier, Robert, et al.
Publicado: (2020)

Alpelisib: A Novel Therapy for Patients With PIK3CA-Mutated Metastatic Breast Cancer
por: Wilhoit, Tori, et al.
Publicado: (2020)

Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
por: Wesolowski, Robert, et al.
Publicado: (2020)

Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge
por: Leung, Mova, et al.
Publicado: (2022)

ODP257 Alpelisib Treatment Associated With Severe Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer
por: Aziz, Shima, et al.
Publicado: (2022)

A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study
por: Zvinovski, Filadelfiya, et al.
Publicado: (2021)

Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
por: Percik, Ruth, et al.
Publicado: (2023)

Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study
por: Morgan, Evan, et al.
Publicado: (2020)

Long-Term Follow-Up of Fractional CO(2) Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors
por: Quick, Allison M., et al.
Publicado: (2022)

Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
por: Benner, Brooke, et al.
Publicado: (2020)

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience
por: Alaklabi, Sabah, et al.
Publicado: (2022)

Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

A Case of Diabetic Keto Acidosis From Alpelisib
por: Thumma, Soumya P, et al.
Publicado: (2021)

Alpelisib-Induced Hyperglycemia- A Small Case Series
por: Ekanayake, Preethika Subashini, et al.
Publicado: (2021)

Case report: Alpelisib-induced Stevens–Johnson syndrome
por: Kurian, Christine Jane, et al.
Publicado: (2022)

Bilateral Panuveitis and Exudative Retinal Detachments Associated with Alpelisib
por: Chong, Yu Jeat, et al.
Publicado: (2022)

Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions
por: Schutte, Tim, et al.
Publicado: (2023)

FRI610 Phosphatidylinositol 3-kinase Inhibition With Alpelisib Is Safe And Effective In Treating Refractory Hypoglycemia Associated With Malignant Insulinoma
por: Mi Kang, Yu, et al.
Publicado: (2023)

Spontaneous Tumor Lysis Syndrome in Metastatic Melanoma
por: Song, Mingchen, et al.
Publicado: (2011)

Association of Tumor Lysis Syndrome and Metastatic Melanoma
por: Kelkar, Neil, et al.
Publicado: (2021)

Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
por: Garneau, Alexandre P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3vtfnst0bhgc752sojjac9ng3d